Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial.
Trials. 2018 Apr 3;19(1):216. doi: 10.1186/s13063-018-2586-7.
Trials. 2018.
PMID: 29615077
Free PMC article.
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE).
Crabb SJ, Danson S, Catto JWF, Hussain S, Chan D, Dunkley D, Downs N, Marwood E, Day L, Saunders G, Light M, Whitehead A, Ellis D, Sarwar N, Enting D, Birtle A, Johnson B, Huddart R, Griffiths G.
Crabb SJ, et al.
Clin Cancer Res. 2021 Apr 1;27(7):1882-1892. doi: 10.1158/1078-0432.CCR-20-3946. Epub 2021 Jan 20.
Clin Cancer Res. 2021.
PMID: 33472913
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite